Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.0500
0.00 (0.00%)
Apr 28, 2026, 3:55 PM EST
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $231.04 thousand as of April 29, 2026. Its market cap has decreased by -91.11% in one year.
Market Cap
231.04K
Enterprise Value
-1.36M
Revenue
389.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 231.04K, a decrease of -99.15%. That is a compound annual growth rate of -75.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 231.04K | -72.22% |
| Dec 31, 2025 | 831.75K | -77.44% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
| Dec 20, 2022 | 27.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Altamira Therapeutics | 457.24K |
| Sorrento Therapeutics | 434.97K |
| Actavia Life Sciences | 385.91K |
| CNBX Pharmaceuticals | 367.73K |
| THC Farmaceuticals | 326.37K |
| Helix BioMedix | 224.71K |
| Regen BioPharma | 201.47K |
| GB Sciences | 158.82K |